Overview

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Status:
Recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

Study to compare the efficacy and safety of colchicine and glucocorticoids compared with the standard of treatment for moderate/severe COVID-19 in a fragile and vulnerable population, admitted to a geriatric hospital unit or in a transicional care center

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Maria Joyera Rodríguez

Treatments:

Colchicine
Prednisone